enGene Holdings Inc. (NASDAQ: ENGN) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ENGENE HOLDINGS INC.

enGene Holdings Inc. (NASDAQ: ENGN)
Listen to this Section


$1.63
-0.0950 ( -5.52% ) 675.8K

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Market Data


Open $1.63
Previous Close $1.72
Volume 675.8K
Market Cap $111.87M
Day Range $1.63 - $1.76
52 Week Range $1.40 - $12.25
Shares Outstanding 66.99M
Change % -5.52%
Net Change ▼ -0.0950
Insider Ownership 0.03%
Exchange NASDAQ
SectorHealthcare
Industry
IPO Year2023
CountryCanada
UnderwriterUBS Investment Bank, Kempen, more

Insider Ownership Transactions

Total Amount Purchased: -4,896,018.00

Date Type Amount Purchased Purchaser
2023-11-02 Sale -177935.00 Nichols Alexander Julian
2023-11-02 Sale -88901.00 Sullivan James Crowley
2023-11-02 Sale -24555.00 Glickman Richard M
2023-11-02 Sale -1341790.00 BRUNK GERALD A
2023-11-02 Sale -130085.00 Forbion Growth Sponsor FEAC I B.V.
2023-11-02 Sale -137051.00 Hanson Jason David

SEC Filings


Form Type Description Pages Date
424b5 Other 3 Nov 14, 2025
8-k 8K-related 23 Nov 14, 2025
schedule Other 1 Nov 14, 2025
424b5 Other 3 Nov 12, 2025
8-k 8K-related 64 Nov 12, 2025
8-k 8K-related 10 Oct 02, 2025
8-k/a 8K-related 10 Oct 02, 2025
4 Insider transactions 1 Oct 01, 2025
3 Insider transactions 2 Oct 01, 2025
8-k 8K-related 12 Sep 30, 2025

Latest News


× Before browsing our site, please accept our cookies policy